Tampereen yliopistollinen sairaala (TAYS)

Tampere 33521

1 studies enrolling now · 2 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer — Completed